Exploring the elephant: histopathology in high-throughput phenotyping of mutant mice

Recent advances in gene knockout techniques and the in vivo analysis of mutant mice, together with the advent of large-scale projects for systematic mouse mutagenesis and genome-wide phenotyping, have allowed the creation of platforms for the most complete and systematic analysis of gene function ev...

Full description

Bibliographic Details
Main Authors: Paul N. Schofield, Peter Vogel, Georgios V. Gkoutos, John P. Sundberg
Format: Article
Language:English
Published: The Company of Biologists 2012-01-01
Series:Disease Models & Mechanisms
Online Access:http://dmm.biologists.org/content/5/1/19
id doaj-d2a0d13f591844a68d33fd0c6c931087
record_format Article
spelling doaj-d2a0d13f591844a68d33fd0c6c9310872020-11-25T01:20:03ZengThe Company of BiologistsDisease Models & Mechanisms1754-84031754-84112012-01-0151192510.1242/dmm.008334008334Exploring the elephant: histopathology in high-throughput phenotyping of mutant micePaul N. SchofieldPeter VogelGeorgios V. GkoutosJohn P. SundbergRecent advances in gene knockout techniques and the in vivo analysis of mutant mice, together with the advent of large-scale projects for systematic mouse mutagenesis and genome-wide phenotyping, have allowed the creation of platforms for the most complete and systematic analysis of gene function ever undertaken in a vertebrate. The development of high-throughput phenotyping pipelines for these and other large-scale projects allows investigators to search and integrate large amounts of directly comparable phenotype data from many mutants, on a genomic scale, to help develop and test new hypotheses about the origins of disease and the normal functions of genes in the organism. Histopathology has a venerable history in the understanding of the pathobiology of human and animal disease, and presents complementary advantages and challenges to in vivo phenotyping. In this review, we present evidence for the unique contribution that histopathology can make to a large-scale phenotyping effort, using examples from past and current programmes at Lexicon Pharmaceuticals and The Jackson Laboratory, and critically assess the role of histopathology analysis in high-throughput phenotyping pipelines.http://dmm.biologists.org/content/5/1/19
collection DOAJ
language English
format Article
sources DOAJ
author Paul N. Schofield
Peter Vogel
Georgios V. Gkoutos
John P. Sundberg
spellingShingle Paul N. Schofield
Peter Vogel
Georgios V. Gkoutos
John P. Sundberg
Exploring the elephant: histopathology in high-throughput phenotyping of mutant mice
Disease Models & Mechanisms
author_facet Paul N. Schofield
Peter Vogel
Georgios V. Gkoutos
John P. Sundberg
author_sort Paul N. Schofield
title Exploring the elephant: histopathology in high-throughput phenotyping of mutant mice
title_short Exploring the elephant: histopathology in high-throughput phenotyping of mutant mice
title_full Exploring the elephant: histopathology in high-throughput phenotyping of mutant mice
title_fullStr Exploring the elephant: histopathology in high-throughput phenotyping of mutant mice
title_full_unstemmed Exploring the elephant: histopathology in high-throughput phenotyping of mutant mice
title_sort exploring the elephant: histopathology in high-throughput phenotyping of mutant mice
publisher The Company of Biologists
series Disease Models & Mechanisms
issn 1754-8403
1754-8411
publishDate 2012-01-01
description Recent advances in gene knockout techniques and the in vivo analysis of mutant mice, together with the advent of large-scale projects for systematic mouse mutagenesis and genome-wide phenotyping, have allowed the creation of platforms for the most complete and systematic analysis of gene function ever undertaken in a vertebrate. The development of high-throughput phenotyping pipelines for these and other large-scale projects allows investigators to search and integrate large amounts of directly comparable phenotype data from many mutants, on a genomic scale, to help develop and test new hypotheses about the origins of disease and the normal functions of genes in the organism. Histopathology has a venerable history in the understanding of the pathobiology of human and animal disease, and presents complementary advantages and challenges to in vivo phenotyping. In this review, we present evidence for the unique contribution that histopathology can make to a large-scale phenotyping effort, using examples from past and current programmes at Lexicon Pharmaceuticals and The Jackson Laboratory, and critically assess the role of histopathology analysis in high-throughput phenotyping pipelines.
url http://dmm.biologists.org/content/5/1/19
work_keys_str_mv AT paulnschofield exploringtheelephanthistopathologyinhighthroughputphenotypingofmutantmice
AT petervogel exploringtheelephanthistopathologyinhighthroughputphenotypingofmutantmice
AT georgiosvgkoutos exploringtheelephanthistopathologyinhighthroughputphenotypingofmutantmice
AT johnpsundberg exploringtheelephanthistopathologyinhighthroughputphenotypingofmutantmice
_version_ 1725135772963569664